Searching News Database: Conjuchem Biotechnologies
HSMN NewsFeed - 24 Feb 2014
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
HSMN NewsFeed - 14 Jul 2006
Conjuchem announces clinical hold of its DAC(TM):GRF Program in HIV Lipodystrophy
Conjuchem announces clinical hold of its DAC(TM):GRF Program in HIV Lipodystrophy
